CareDx (CDNA) earnings history
Most recent quarter
- Fiscal period
- Q2 2026
- Period end
- Jun 30, 2026
- EPS actual
- $0.37
- EPS estimate
- $0.23
- EPS surprise
- +59.41%
- Revenue surprise
- +15.92%
- Revenue
- $131.9M
- Revenue estimate
- $113.8M
- Reported
- Jul 30, 2026
CareDx reported Q2 2026 results on July 30, 2026. Earnings per share were $0.37, beating the $0.23 estimate by 59.41%. Revenue of $131.9 million topped the $113.8 million consensus by about 16%. In Q2 2025 CareDx lost $0.16 per share, so the result swung to a profit, and revenue rose about 52% from $86.7 million.
CareDx lost money in 15 of the 20 quarters in the table, including every quarter from Q3 2021 to Q3 2024. Q4 2024 was an exception at $1.51 per share, the high in the table, and the last four quarters were all profitable. Annual EPS was a loss of $1.44 in 2022 and $3.54 in 2023, a profit of $1.02 in 2024 and a loss of $0.20 in 2025. Annual revenue dipped to $280.4 million in 2023, then grew 19% in 2024 and 14% in 2025. CareDx beat the EPS estimate in each of the last four quarters and in 12 of the last 20.
Q3 reports came between October 28 and November 8 in each of the past five years. That points to early November 2026 for the next report. It will show whether the run of profitable quarters continues.
Earnings history
| Period | Reported | EPS estimate | EPS actual | Surprise | Revenue | Filing |
|---|---|---|---|---|---|---|
| Q2 2026 | Jul 30, 2026 | $0.23 | $0.37 | +59.41% | $131.9M | SEC |
| Q1 2026 | Apr 28, 2026 | $0.13 | $0.34 | +154.68% | $117.7M | SEC |
| Q4 2025 | Feb 24, 2026 | $0.02 | $0.12 | +503.02% | $108.4M | SEC |
| Q3 2025 | Nov 4, 2025 | −$0.08 | $0.03 | +136.63% | $100.1M | SEC |
| Q2 2025 | Aug 6, 2025 | −$0.10 | −$0.16 | −65.98% | $86.7M | SEC |
| Q1 2025 | Apr 30, 2025 | −$0.21 | −$0.19 | +8.08% | $84.7M | SEC |
| Q4 2024 | Feb 26, 2025 | −$0.41 | $1.51 | +469.92% | $86.6M | SEC |
| Q3 2024 | Nov 4, 2024 | −$0.25 | −$0.14 | +43.14% | $82.9M | SEC |
| Q2 2024 | Jul 31, 2024 | −$0.40 | −$0.03 | +92.48% | $92.3M | SEC |
| Q1 2024 | May 9, 2024 | −$0.47 | −$0.32 | +32.42% | $72.0M | SEC |
| Q4 2023 | Feb 28, 2024 | −$0.45 | −$2.21 | −394.74% | $65.6M | SEC |
| Q3 2023 | Nov 8, 2023 | −$0.59 | −$0.43 | +26.91% | $67.2M | SEC |
| Q2 2023 | Aug 8, 2023 | −$0.54 | −$0.46 | +15.53% | $70.3M | SEC |
| Q1 2023 | May 10, 2023 | −$0.32 | −$0.44 | −36.31% | $77.3M | SEC |
| Q4 2022 | Feb 27, 2023 | −$0.33 | −$0.34 | −1.86% | $82.4M | SEC |
| Q3 2022 | Nov 3, 2022 | −$0.39 | −$0.32 | +18.37% | $79.4M | SEC |
| Q2 2022 | Aug 4, 2022 | −$0.34 | −$0.41 | −20.59% | $80.6M | SEC |
| Q1 2022 | May 5, 2022 | −$0.28 | −$0.37 | −34.55% | $79.4M | SEC |
| Q4 2021 | Feb 24, 2022 | −$0.14 | −$0.31 | −124.64% | $79.2M | SEC |
| Q3 2021 | Oct 28, 2021 | −$0.14 | −$0.23 | −67.27% | $75.6M | SEC |
Quarterly revenue
Frequently asked questions
When did CareDx (CDNA) last report earnings?
CareDx last reported on Jul 30, 2026, covering fiscal Q2 2026.
Did CDNA beat earnings estimates?
Yes. CareDx reported EPS of $0.37 for Q2 2026 against a $0.23 estimate — a 59.41% beat.
How much revenue did CDNA report last quarter?
CareDx reported $131.9M in revenue for Q2 2026, against a consensus estimate of $113.8M.
Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.